The global tissue diagnostics market is growing
significantly due to increasing prevalence of cancer, and technological
advancements in tissue diagnostics.
Increasing prevalence of cancer has fuelled the demand of
better diagnostic techniques, which could detect cancer in the earliest stage.
According to the WHO, in 2012, there were 14 million new cancer cases and 8.2
million cancer related deaths worldwide.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/tissue-diagnostics-market/report-sample
Some of the factors driving the growth of the global tissue
diagnostics market are increasing prevalence of cancer, increasing investment
in tissue diagnostics by pharmaceutical companies, rising awareness for cancer,
rapidly aging population, technological advancements in tissue diagnostics
procedures, and increasing healthcare expenditure. In addition, tissue
diagnostic procedures enable medical professionals to detect cancer in early
stage; hence, fueling the growth of the market.
Full Explore Report@ https://www.psmarketresearch.com/market-analysis/tissue-diagnostics-market
Geographically, North America will be leading the global
tissue diagnostics market in the coming years due to high prevalence of cancer
cases, high healthcare expenditure, and presence of a large number of hospitals
and pharmaceutical companies.
Asia-Pacific is the fastest growing region in the global
tissue diagnostics market. The major reasons for the fastest growth in the
region are aging population, increasing disposable income, and improving
healthcare infrastructure. Moreover, the tissue diagnostics marketis growing
due to large unexplored tissue diagnostics market and large population base
suffering with cancer in the emerging economies, such as India and China, of
Asia-Pacific region.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=tissue-diagnostics-market
Some of the major players operating in the global tissue
diagnostics market are F. Hoffmann-La Roche AG., Sigma Aldrich Corporation,
Abbott, Biogenex Laboratories, BioSB, Cell Signalling Technology Inc., Thermo
Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, GE
Healthcare, and Siemens Healthcare.
About P&S Intelligence
P&S Intelligence, a brand of P&S
Market Research, is a provider of market research and consulting services
catering to the market information needs of burgeoning industries across the
world. Providing the plinth of market intelligence, P&S as an enterprising
research and consulting company, believes in providing thorough landscape
analyses on the ever-changing market scenario, to empower companies to make
informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
No comments:
Post a Comment